Parametrial boosting in locally advanced cervical cancer: Combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy

Brachytherapy

Volumn 14, Issue 1, 2015, Pages 23-28

  Mohamed, Sandy ^a,b   Kallehauge, Jesper ^a   Fokdal, Lars ^a   Lindegaard, Jacob Christian ^a   Tanderup, Kari ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b CAIRO UNIVERSITY   (Egypt)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Cervical cancer; Image guided brachytherapy; Interstitial brachytherapy; Midline block; Parametrial boost

Indexed keywords

ADVANCED CANCER; ARTICLE; BLADDER; BRACHYTHERAPY; CANCER RADIOTHERAPY; COMBINED INTRACAVITARY INTERSTITIAL BRACHYTHERAPY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTESTINE; INTRACAVITARY BRACHYTHERAPY; MAJOR CLINICAL STUDY; ORGANS AT RISK; PARAMETRIAL BOOST; RADIATION DOSE FRACTIONATION; RADIOLOGICAL PARAMETERS; RECTUM; SIGMOID; UTERINE CERVIX CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONSERVATIVE TREATMENT; IMAGE GUIDED RADIOTHERAPY; MIDDLE AGED; PROCEDURES; RADIATION DOSE; UTERINE CERVICAL NEOPLASMS;

BRACHYTHERAPY; FEMALE; HUMANS; MIDDLE AGED; ORGAN SPARING TREATMENTS; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; UTERINE CERVICAL NEOPLASMS;

EID: 84919608327     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2014.09.010     Document Type: Article

References (35)

1. Haie-Meder C., Pötter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005, 74:235-245.
2. Pötter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
3. Pötter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007, 83:148-155.
4. Lindegaard J.C., Tanderup K., Nielsen S.K., et al. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008, 71:756-764.
5. Dimopoulos J.C., Lang S., Kirisits C., et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009, 75:56-63.
6. Pötter R., Georg P., Dimopoulos J.C., et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011, 100:116-123.
7. Lindegaard J.C., Fokdal L.U., Nielsen S.K., et al. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013, 52:1510-1519.
8. Benedetti-Panici P., Maneschi F., Scambia G., et al. Lymphatic spread of cervical cancer: An anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996, 62:19-24.
9. Zreik T.G., Chambers J.T., Chambers S.K. Parametrial involvement, regardless of nodal status: A poor prognostic factor for cervical cancer. Obstet Gynecol 1996, 87(5 Pt 1):741-746.
10. Wright J.D., Grigsby P.W., Brooks R., et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer 2007, 110:1281-1286.
11. Hsu H.C., Leung S.W., Huang E.Y., et al. Impact of the extent of parametrial involvement in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1998, 40:405-410.
12. Logsdon M.D., Eifel P.J. FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999, 43:763-775.
13. Dimopoulos J.C., Potter R., Lang S., et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009, 93:311-315.
14. Viswanathan A.N., Creutzberg C.L., Craighead P., et al. International brachytherapy practice patterns: A survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys 2012, 82:250-255.
15. Wolfson A.H., bdel-Wahab M., Markoe A.M., et al. A quantitative assessment of standard vs. customized midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys 1997, 37:237-242.
16. Popple R.A., Kim R.Y., Pareek P., et al. Custom step wedge blocking using dynamic multileaf collimation for parametrial pelvic boost irradiation following brachytherapy for carcinoma of the cervix. Med Phys 2003, 30:2699-2702.
17. Fokdal L., Tanderup K., Hokland S.B., et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol 2013, 107:63-68.
18. Dimopoulos J.C., Kirisits C., Petric P., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006, 66:83-90.
19. Kirisits C., Lang S., Dimopoulos J., et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006, 65:624-630.
20. Fenkell L., Assenholt M.S., Nielsen S.K., et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs-at-risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2011, 79:1572-1579.
21. Dimopoulos J.C., Petrow P., Tanderup K., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012, 103:113-122.
22. Hellebust T.P., Kirisits C., Berger D., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010, 96:153-160.
23. Georg P., Potter R., Georg D., et al. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys 2012, 82:653-657.
24. Barillot I., Horiot J.C., Maingon P., et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies. Int J Radiat Oncol Biol Phys 2000, 48:189-200.
25. Huang E.Y., Lin H., Hsu H.C., et al. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer. Gynecol Oncol 2000, 79:406-410.
26. McLntyre J.F., Eifel P.J., Levenback C., et al. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer 1995, 75:836-843.
27. Good J., Lalondrelle S., Blake P. Point: Parametrial irradiation in locally advanced cervix cancer can be achieved effectively with a variety of external beam techniques. Brachytherapy 2012, 11:77-79.
28. Georg D., Kirisits C., Hillbrand M., et al. Image-guided radiotherapy for cervix cancer: High-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 2008, 71:1272-1278.
29. Assenholt M.S., Petersen J.B., Nielsen S.K., et al. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta Oncol 2008, 47:1337-1343.
30. Tanderup K., Nielsen S.K., Nyvang G.B., et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010, 94:173-180.
31. Nomden C.N., de Leeuw A.A., Moerland M.A., et al. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2012, 82:1424-1430.
32. Lindegaard J.C., Tanderup K. Counterpoint: Time to retire the parametrial boost. Brachytherapy 2012, 11:80-83.
33. van de Bunt L., Jurgenliemk-Schulz I.M., de Kort G.A., et al. Motion and deformation of the target volumes during IMRT for cervical cancer: What margins do we need?. Radiother Oncol 2008, 88:233-240.
34. Lim K., Kelly V., Stewart J., et al. Pelvic radiotherapy for cancer of the cervix: Is what you plan actually what you deliver?. Int J Radiat Oncol Biol Phys 2009, 74:304-312.
35. Lee J.E., Han Y., Huh S.J., et al. Interfractional variation of uterine position during radical RT: Weekly CT evaluation. Gynecol Oncol 2007, 104:145-151.